Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients

Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients

Chronic kidney disease patients, especially those on hemodialysis, are at the highest risk of a severe course and death from COVID-19. Moreover, they appear to have suboptimal response in both cellular and humoral immunity after vaccination. The present study investigated humoral and cellular respon...

Full description

Bibliographic Details
Main Authors: Paraskevi Tsoutsoura, Efstathios Xagas, Kyriaki Kolovou, Polyxeni Gourzi, Sotirios Roussos, Angelos Hatzakis, Ioannis N. Boletis, Smaragdi Marinaki
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Infectious Disease Reports
Subjects:
SARS-CoV-2 vaccination
hemodialysis
mRNA vaccine
Online Access:https://www.mdpi.com/2036-7449/14/6/93

Internet

https://www.mdpi.com/2036-7449/14/6/93

Similar Items